J&J hands Congress 20K pages of Tylenol documentation

J&J continues to hand over to Congress some 20,000 pages of documentation concerning the Tylenol and other children's medication recalls that originated at its GMP-violation-riddled Pennsylvania plant. The page count exceeds 20,000, with more to come. The documents are stacked in the House Oversight and Government Reform Committee in-box, on top of more than 1,000 pages collected from the of FDA. Report

Suggested Articles

Popular logic says you never switch horses, or CDMOs, in the middle of the stream, but Acacia Pharma had to do that to win an FDA approval.

The FDA has found issues with the testing practices of a U.S. generics maker that had specific problems with ADHD and weight-loss drugs.

A warning letter says Chinese API maker Yibin Lihao Bio-technical was found lying to the FDA about manufacturing unapproved heparin.